From our beginnings in electrophysiology in CNS care to today’s focus on better CNS clinical development through meaningful endpoints, our journey over the past 8 years has been one of constant growth, adaptation, and innovation. We’ve evolved alongside the needs of the market, continuously seeking new ways to make CNS trials more insightful, efficient, and impactful.
Here is to some of our proudest achievements:
- Partnering with biotech, pharma and MedTech to enrich 20+ clinical trials with our insight-led service using our FDA-approved electrophysiology solutions across different CNS indications.
- Embracing diverse digital health technologies beyond our own, curating partnerships that bring multi-modal data solutions to the forefront of CNS trials.
- Securing Series A funding to evolve this into a fully fledged and tech-enabled value proposition, aiming to set a new approach and standard for data-driven insights in CNS trials.
None of this would have been possible without the support and collaboration of our incredible team and the ecosystem: our partners in biotech, pharma, and digital health technology, the brilliant KOLs who help guide our mission, and all the stakeholders who believe in our purpose and ambition. Thank you for growing with us and shaping the future of CNS trials.
Together, we’re driving change, and we’re just getting started. Here’s to many more years of innovation, impact, and meaningful progress.
